← Leaderboards
Aaron Grossberg
Oregon Health & Science University
$3,764,595
Attributed
$3,764,595
Total exposure
4
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.1M · FY2009–25$2M$1.5M$1M$500K$0
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$3,764,595 · 4
By mechanism
R01$1,268,030 · 1
K08$1,191,731 · 1
R37$1,127,838 · 1
F30$176,996 · 1
Top collaborators
No co-investigators on record.
Most similar at Oregon Health & Science University
Same institution · by research overlap
- Julia E Maxson$5,322,132
- Brennan Glenn Olson$97,239
- Kolter Grigsby$682,175
Others in their field
Top investigators on “Quality Of Life”
- Gary D Acton · University Of California-Davis$320,373,312
- Mitchell J Malone · Texas A&M Research Foundation$320,373,312
- Gerald T Nepom · Benaroya Research Inst At Virginia Mason$298,740,071
- Gregory H Reaman · National Childhood Cancer Foundation$264,644,476
- David R. Weir · University Of Michigan At Ann Arbor$263,050,576
- Richard K. Wilson · Washington University$198,912,538
Research focus
Quality Of LifeMetabolicSignal TransductionMalignant NeoplasmsTumorCachexiaResponsePhysiologyMonitorEffective TherapyWasting SyndromeDesignMediatingWastingInsightCancer CachexiaSkeletal MuscleMuscleAdipose TissueOrganPancreatic Ductal AdenocarcinomaCatabolismMorbidity - Disease RateLife
Grant awards (15)
PQ6: Therapeutic approaches for autonomic and neuroendocrine dysfunction in cancer cachexia$432,774
R01 · FY2025 · CA · contact PI
Metabolic vulnerability due to dysregulated lipid metabolism in PDAC cachexia$377,780
R37 · FY2025 · CA · contact PI
PQ6: Therapeutic approaches for autonomic and neuroendocrine dysfunction in cancer cachexia$411,136
R01 · FY2024 · CA · contact PI
Metabolic vulnerability due to dysregulated lipid metabolism in PDAC cachexia$361,006
R37 · FY2024 · CA · contact PI
Hepatic metabolic reprogramming drives pancreatic cancer cachexia$200,031
K08 · FY2024 · CA · contact PI
PQ6: Therapeutic approaches for autonomic and neuroendocrine dysfunction in cancer cachexia$424,120
R01 · FY2023 · CA · contact PI
Metabolic vulnerability due to dysregulated lipid metabolism in PDAC cachexia$389,052
R37 · FY2023 · CA · contact PI
Hepatic metabolic reprogramming drives pancreatic cancer cachexia$247,925
K08 · FY2023 · CA · contact PI
Hepatic metabolic reprogramming drives pancreatic cancer cachexia$247,925
K08 · FY2022 · CA · contact PI
Hepatic metabolic reprogramming drives pancreatic cancer cachexia$247,925
K08 · FY2021 · CA · contact PI
Hepatic metabolic reprogramming drives pancreatic cancer cachexia$247,925
K08 · FY2020 · CA · contact PI
Inflammatory Cytokine regulation of POMC and Orexin neurons in cachexia.$43,131
F30 · FY2012 · DK · contact PI
Inflammatory Cytokine regulation of POMC and Orexin neurons in cachexia.$46,800
F30 · FY2011 · DK · contact PI
Inflammatory Cytokine regulation of POMC and Orexin neurons in cachexia.$44,080
F30 · FY2010 · DK · contact PI
Inflammatory Cytokine regulation of POMC and Orexin neurons in cachexia.$42,985
F30 · FY2009 · DK · contact PI